Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Laporte

Showing results (51-60 of 185) with videos related to

Pageof 19
Sort By:
Medicina Clinica|June 18, 1988
[Detection of adverse reactions to drugs from the hospital admission diagnosis. Method and results]L Armadans, X Carné, J R Laporte
Medicina Clinica|November 26, 1983
[The evaluation of drugs after their commercialization]J R Laporte, X Carné, M Porta
Actas Dermo-Sifiliograficas|November 1, 1974
[Cutaneous complications of analgesic injections]J Vidal, J R Laporte, C Benasco
Drug Safety|November 1, 1991
Adverse drug reactions leading to hospital admissionL Ibáñez, J R Laporte, X Carné
Archivos De Farmacologia Y Toxicologia|April 1, 1983
[Agranulocytosis in the Barcelona area. Results of 2 years' follow-up]L Ibáñez, X Carné, J R Laporte
European Journal of Clinical Pharmacology|January 1, 1990
Agranulocytosis induced by cinepazideJ R Laporte, D Capellà, J Juan
Journal of Molecular and Cellular Cardiology|March 1, 1994
Phorbol ester-induced potentiation of myogenic tone is not associated with increases in Ca2+ influx, myoplasmic free Ca2+ concentration, or 20-kDa myosin light chain phosphorylationR Laporte, J R Haeberle, I Laher
Neurology|October 27, 2004
Oral antispastic drugs in nonprogressive neurologic diseases: a systematic reviewE Montané, A Vallano, J R Laporte
European Journal of Clinical Pharmacology|January 1, 1983
Utilization of antihypertensive drugs in certain European countriesD Capellà, M Porta, J R Laporte
Archivos De Farmacologia Y Toxicologia|April 1, 1983
[Bone marrow aplasia in the Barcelona area. Result of the 1st 2 years of follow-up]X Carné, L Ibáñez, J R Laporte
Pageof 19

Showing results (51-60 of 185) with videos related to

Sort By:
Pageof 19
Medicina Clinica|June 18, 1988
[Detection of adverse reactions to drugs from the hospital admission diagnosis. Method and results]L Armadans, X Carné, J R Laporte
Medicina Clinica|November 26, 1983
[The evaluation of drugs after their commercialization]J R Laporte, X Carné, M Porta
Actas Dermo-Sifiliograficas|November 1, 1974
[Cutaneous complications of analgesic injections]J Vidal, J R Laporte, C Benasco
Drug Safety|November 1, 1991
Adverse drug reactions leading to hospital admissionL Ibáñez, J R Laporte, X Carné
Archivos De Farmacologia Y Toxicologia|April 1, 1983
[Agranulocytosis in the Barcelona area. Results of 2 years' follow-up]L Ibáñez, X Carné, J R Laporte
European Journal of Clinical Pharmacology|January 1, 1990
Agranulocytosis induced by cinepazideJ R Laporte, D Capellà, J Juan
Journal of Molecular and Cellular Cardiology|March 1, 1994
Phorbol ester-induced potentiation of myogenic tone is not associated with increases in Ca2+ influx, myoplasmic free Ca2+ concentration, or 20-kDa myosin light chain phosphorylationR Laporte, J R Haeberle, I Laher
Neurology|October 27, 2004
Oral antispastic drugs in nonprogressive neurologic diseases: a systematic reviewE Montané, A Vallano, J R Laporte
European Journal of Clinical Pharmacology|January 1, 1983
Utilization of antihypertensive drugs in certain European countriesD Capellà, M Porta, J R Laporte
Archivos De Farmacologia Y Toxicologia|April 1, 1983
[Bone marrow aplasia in the Barcelona area. Result of the 1st 2 years of follow-up]X Carné, L Ibáñez, J R Laporte
Pageof 19